Article
Exosomal CircRNA-MANBA Mediates Hepatocellular Carcinoma Sorafenib Resistance via miR-1290/CD109/p-STAT3 Axis
2023-10-24
Abstract excerpt
<title>Abstract</title> <p>Background Sorafenib remains the cornerstone chemotherapeutic treatment for patients with late-stage hepatocellular carcinoma (HCC). Unfortunately, resistance to this drug in the context of the disease is frequent, and the underlying mechanisms remain unclear. In this regard, exosome-contained noncoding RNAs (ncRNAs) have been proven to participate in various diseases. Here, we aimed t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1fcde8da-4dd2-5ccc-aa98-232b78c213ff
- DOI
- 10.21203/rs.3.rs-3431574/v1
